Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aisner

Showing results (101-110 of 235) with videos related to

Pageof 24
Sort By:
JAMA|February 1, 1980
Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparationsP A Daly, C A Schiffer, J Aisner, et al.
Transfusion|January 1, 1984
Donor reaction to hydroxyethyl starch during granulocytapheresisJ P Dutcher, J Aisner, D E Hogge, et al.
Transfusion|November 1, 1979
A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresisP A Daly, C A Schiffer, J Aisner, et al.
American Journal of Hematology|June 1, 1983
Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusionD E Hogge, J P Dutcher, J Aisner, et al.
Cancer|December 15, 1982
Possible pulmonary toxicity secondary to vinblastineP H Konits, J Aisner, J C Sutherland, et al.
Cancer Treatment Reports|August 1, 1980
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinomaD A Van Echo, S Markus, J Aisner, et al.
Blood|March 1, 1981
Alloimmunization following platelet transfusion: the absence of a dose-response relationshipJ P Dutcher, C A Schiffer, J Aisner, et al.
Transfusion|January 1, 1981
Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresisJ Aisner, C A Schiffer, P A Daly, et al.
Blood|November 1, 1981
Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunizedJ P Dutcher, C A Schiffer, J Aisner, et al.
American Journal of Hematology|August 1, 1983
Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemiaC A Schiffer, J Aisner, J P Dutcher, et al.
Pageof 24

Showing results (101-110 of 235) with videos related to

Sort By:
Pageof 24
JAMA|February 1, 1980
Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparationsP A Daly, C A Schiffer, J Aisner, et al.
Transfusion|January 1, 1984
Donor reaction to hydroxyethyl starch during granulocytapheresisJ P Dutcher, J Aisner, D E Hogge, et al.
Transfusion|November 1, 1979
A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresisP A Daly, C A Schiffer, J Aisner, et al.
American Journal of Hematology|June 1, 1983
Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusionD E Hogge, J P Dutcher, J Aisner, et al.
Cancer|December 15, 1982
Possible pulmonary toxicity secondary to vinblastineP H Konits, J Aisner, J C Sutherland, et al.
Cancer Treatment Reports|August 1, 1980
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinomaD A Van Echo, S Markus, J Aisner, et al.
Blood|March 1, 1981
Alloimmunization following platelet transfusion: the absence of a dose-response relationshipJ P Dutcher, C A Schiffer, J Aisner, et al.
Transfusion|January 1, 1981
Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresisJ Aisner, C A Schiffer, P A Daly, et al.
Blood|November 1, 1981
Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunizedJ P Dutcher, C A Schiffer, J Aisner, et al.
American Journal of Hematology|August 1, 1983
Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemiaC A Schiffer, J Aisner, J P Dutcher, et al.
Pageof 24